BioSpace News Archive

CVS Pharmacy, the retail division of CVS Health, announced that it has completed the rollout of time delay safes in all of its 58 CVS Pharmacy locations in West Virginia, including pharmacies located in Target stores.

Study highlights lower hospitalization rates in adults 65 years and older living in U.S. nursing homes who received an adjuvanted influenza vaccine versus standard trivalent influenza vaccine

Gift is one of the largest ever to Beaumont, will support emergency medicine and future hospital needs

Download White Paper with documentation and guidance: “Understanding NAFLD and NASH in the Non-Liver Specialist Setting”

Partnership leverages transformational science from Talix and global oncology capabilities of Samyang to target areas of significant unmet medical need in cancer patients

Financial terms of Paine Schwartz’s investment in Warburton Technology were not disclosed.

According to Coherent Market Insights, the global neurological disorder diagnostics market is expected to be valued at US$ 12,162.6 million in 2019, and is expected to exhibit a CAGR of 7.6% over the forecast period.

The presentation is taking place today, December 9, 2019, at the Annual Meeting of the American College of Neuropsychopharmacology in Orlando, Florida.

Two oral presentations and one poster presentation focus on novel inhibitors of the Sec61 translocon, which demonstrate high degrees of potency against a large number of therapeutically relevant oncology and immuno-oncology targets that are Sec61 client proteins, translating into broad anti-tumor activity.

The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering.